- Filed
- Aug 20, 2015 12:00 AM ET
- Period of report
- —
Amendment.
Amends a previously filed report.
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q2 2015 · Aug 11, 2015 | 139.22M sh |
| Capex | Q2 2015 · Jun 30, 2015 | $3.36M |
| Capex restated | Q2 2015 · Jun 30, 2014 | $6.56M |
| Operating Cash Flow | Q2 2015 · Jun 30, 2015 | −$3.12M |
| Operating Cash Flow restated | Q2 2015 · Jun 30, 2014 | $1.29M |
| Short Term Debt | Q2 2015 · Jun 30, 2015 | $26.83M |
| Short Term Debt | Q2 2015 · Dec 31, 2014 | $25.86M |
| Stockholders Equity | Q2 2015 · Jun 30, 2015 | −$32.48M |
| Stockholders Equity | Q2 2015 · Dec 31, 2014 | −$23.01M |
| Current Liabilities | Q2 2015 · Jun 30, 2015 | $88.5M |
| Current Liabilities | Q2 2015 · Dec 31, 2014 | $49.78M |
| Total Liabilities | Q2 2015 · Jun 30, 2015 | $88.5M |
| Total Liabilities | Q2 2015 · Dec 31, 2014 | $77.83M |
| Current Assets | Q2 2015 · Jun 30, 2015 | $391.18K |
| Current Assets | Q2 2015 · Dec 31, 2014 | $653.66K |
| Total Assets | Q2 2015 · Jun 30, 2015 | $56.02M |
| Total Assets | Q2 2015 · Dec 31, 2014 | $54.82M |
| Sga Expense | Q2 2015 · Jun 30, 2015 | $2.72M |
| Sga Expense | Q2 2015 · Jun 30, 2015 | $5.79M |
| Sga Expense restated | Q2 2015 · Jun 30, 2014 | $3.01M |
| Sga Expense restated | Q2 2015 · Jun 30, 2014 | $4.98M |
| Net Income | Q2 2015 · Jun 30, 2015 | −$4.3M |
| Net Income | Q2 2015 · Jun 30, 2015 | −$12.9M |
| Net Income restated | Q2 2015 · Jun 30, 2014 | −$23.94M |
| Net Income restated | Q2 2015 · Jun 30, 2014 | −$31.26M |
| Operating Income | Q2 2015 · Jun 30, 2015 | −$4.1M |
| Operating Income | Q2 2015 · Jun 30, 2015 | −$7.76M |
| Operating Income restated | Q2 2015 · Jun 30, 2014 | −$5.59M |
| Operating Income restated | Q2 2015 · Jun 30, 2014 | −$7.7M |
| Cost Of Revenue | Q2 2015 · Jun 30, 2015 | $864.52K |
| Cost Of Revenue | Q2 2015 · Jun 30, 2015 | $1.93M |
| Cost Of Revenue restated | Q2 2015 · Jun 30, 2014 | $799.68K |
| Cost Of Revenue restated | Q2 2015 · Jun 30, 2014 | $1.77M |
| Cash And Equivalents | Q2 2015 · Dec 31, 2014 | $99.33K |
| Cash And Equivalents restated | Q2 2015 · Jun 30, 2014 | $137.59K |
| Cash And Equivalents restated | Q2 2015 · Dec 31, 2013 | $170.95K |